Boston Therapeutics (BTI)

We Are Innovators of Novel Therapies and Diagnostics for Unmet Medical Needs


Read More

Sugardown®

First Line of Defense Against Dietary Free Sugar!


Read More

BTI-320

Prevention and Management of
Diabetes and Its Complications


Read More

Sugardown®

Sugardown® Reduces After-Meal Level Up To 60%


Read More

IPOXYN®

Treatment of Ischemic Conditions
Which May Lead to Necrosis


Read More

OXYFEX™

Transfusion & Blood Therapeutics
for Veterinary Care


Read More

ARIA®

Automatic Retinal Imaging Analysis
For Vascular Risk Assessment


Read More

Boston Therapeutics, Inc. (BTHE)

About Boston Therapeutics, Inc.

About Boston Therapeutics

We are a pharmaceutical company focused on the development, manufacturing and commercialization of novel compounds to address unmet medical needs in diabetes.

Learn more

Boston Therapeutics, Inc. Investor Information

Investors

OTCQB: BTHE
Market Cap:

View Investor Relations